Patents by Inventor Erin Strait

Erin Strait has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250319175
    Abstract: The present invention relates to vaccination against animal pathogens using alphavirus-replicon RNA particles and oil adjuvants. To a vaccine, and a kit of parts comprising the replicon particles and the oil adjuvant. Also to methods and uses of making and using the vaccine and the components of the kit.
    Type: Application
    Filed: January 29, 2025
    Publication date: October 16, 2025
    Applicant: INTERVET INC.
    Inventors: Mark A. MOGLER, Erin STRAIT, Ruud Philip Antoon Maria SEGERS
  • Patent number: 12290556
    Abstract: The present invention provides vectors and/or nucleic acid constructs that encode one or more influenza A virus neuraminidase (NA) antigens. The present invention also provides vaccine against influenza A virus comprising such vectors and/or nucleic acid constructs. The present invention further provides methods of making and using the vaccines alone, or in combination with other protective agents.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: May 6, 2025
    Assignee: Intervet Inc.
    Inventors: Mark A. Mogler, Pravina Kitikoon, Supraja Puttamreddy, Erin Strait, Ruud Philip Antoon Maria Segers, Basav Nagaraj
  • Patent number: 12239702
    Abstract: The present invention relates to vaccination against animal pathogens using alphavirus-replicon RNA particles and oil adjuvants. To a vaccine, and a kit of parts comprising the replicon particles and the oil adjuvant. Also to methods and uses of making and using the vaccine and the components of the kit.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: March 4, 2025
    Assignee: INTERVET INC.
    Inventors: Mark A. Mogler, Erin Strait, Ruud Philip Antoon Maria Segers
  • Publication number: 20220023414
    Abstract: The present invention relates to a method of vaccination. Specifically the invention regards to a prime-boost vaccination regimen for protecting a target animal against infection or disease caused by a virus, wherein the vaccination regimen comprises the administration to said target animal of a vaccine comprising a live attenuated form of said virus, followed by the administration to said target animal of a vaccine comprising an RP encoding one or more antigens from said virus.
    Type: Application
    Filed: December 19, 2019
    Publication date: January 27, 2022
    Applicant: Intervet Inc.
    Inventors: Erin Strait, Mark A. Mogler, Pravina Kitikoon, Ruud Philip Antoon Maria Segers, Erwin van den Born
  • Publication number: 20200330585
    Abstract: The present invention provides vectors and/or nucleic acid constructs that encode one or more influenza A virus neuraminidase (NA) antigens. The present invention also provides vaccine against influenza A virus comprising such vectors and/or nucleic acid constructs. The present invention further provides methods of making and using the vaccines alone, or in combination with other protective agents.
    Type: Application
    Filed: December 17, 2018
    Publication date: October 22, 2020
    Applicant: Intervet Inc.
    Inventors: Mark A. Mogler, Pravina Kitikoon, Supraja Puttamreddy, Erin Strait, Ruud Philip Antton Maria SEGERS, Basav Nagaraj
  • Publication number: 20200323975
    Abstract: The present invention relates to vaccination against animal pathogens using alphavirus-replicon RNA particles and oil adjuvants. To a vaccine, and a kit of parts comprising the replicon particles and the oil adjuvant. Also to methods and uses of making and using the vaccine and the components of the kit.
    Type: Application
    Filed: December 3, 2018
    Publication date: October 15, 2020
    Applicant: Intervet Inc.
    Inventors: Mark A. Mogler, Erin Strait, Ruud Philip Antoon Maria Segers
  • Patent number: 9855336
    Abstract: The present invention is drawn to liquid stable swine vaccines that comprise a live porcine virus. The invention is also drawn to the manufacture of such vaccines and methods of vaccinating animal subjects with these vaccines.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: January 2, 2018
    Assignee: Intervet Inc.
    Inventors: Kevin O'Connell, Zhisong Qiao, Brad Eddy, Erin Strait
  • Publication number: 20170014513
    Abstract: The present invention is drawn to liquid stable swine vaccines that comprise a live porcine virus. The invention is also drawn to the manufacture of such vaccines and methods of vaccinating animal subjects with these vaccines.
    Type: Application
    Filed: February 18, 2015
    Publication date: January 19, 2017
    Applicant: Intervet Inc.
    Inventors: Kevin O'Connell, Zhisong Qiao, Brad Eddy, Erin Strait